Home >> Signaling Pathways >> JAK/STAT Signaling

JAK/STAT Signaling(JAK/STAT 信号通路)

Products for  JAK/STAT Signaling

  1. Cat.No. 产品名称 Information
  2. GC62385 Simotinib Simotinib 是一种选择性、特异性、口服生物利用度高的 EGFR 酪氨酸激酶抑制剂,IC50 为 19.9 nM。抗肿瘤活性。
  3. GC62384 Epitinib succinate

    HMPL-813 succinate

    Epitinib succinate 是一种具有口服活性和选择性的表皮生长因子受体酪氨酸激酶抑制剂 (EGFR-TKI),可以透过血脑屏障。Epitinib succinate 可用于癌症研究。
  4. GC62341 Rezivertinib

    BPI-7711

    Rezivertinib (BPI-7711) 是一种口服有效,高选择性和不可逆的第三代 EGFR 酪氨酸激酶抑制剂 (TKI)。Rezivertinib 对常见的激活 EGFR 和抗性T790M 突变具有高效力。Rezivertinib 具有出色的透过中枢神经系统 (CNS) 能力,并具有抗肿瘤活性。
  5. GC62313 Izencitinib

    TD-1473; JNJ-8398

    Izencitinib (TD-1473) 是具有口服活性的、非选择性的、肠道限定的 JAK 抑制剂。Izencitinib (TD-1473) 可用于溃疡性结肠炎研究。
  6. GC62272 AC-4-130 AC-4-130 是一种有效的 STAT5 SH2 结构域抑制剂。AC-4-130 直接与 STAT5 结合并破坏 STAT5 激活、二聚化、核易位和 STAT5 依赖性基因转录。AC-4-130 在 FLT3-ITD 驱动的白血病细胞中诱导细胞周期停滞和细胞凋亡。AC-4-130 具有抗癌活性,可以有效阻断急性髓系白血病 (AML) 中 STAT5 活性的病理水平。
  7. GC62254 Stafib-1 Stafib-1 是首个选择性的 STAT5b SH2 结构域的抑制剂,其 Ki 值为 44 nM,IC50 值为 154 nM。
  8. GC62246 G5-7 G5-7 is an orally active and allosteric JAK2 inhibitor, selectively inhibits JAK2 mediated phosphorylation and activation of EGFR (Tyr1068) and STAT3 by binding to JAK2.
  9. GC62233 2,6-Dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide A TYK2 inhibitor
  10. GC62160 Mobocertinib succinate

    莫博替尼琥珀酸盐; TAK-788 succinate; AP32788 succinate

    An inhibitor of mutant EGFR and HER2 receptors
  11. GC62159 Tucatinib hemiethanolate

    妥卡替尼半乙醇合物,Irbinitinib hemiethanolate; ARRY-380 hemiethanolate; ONT-380 hemiethanolate

    An inhibitor of HER2
  12. GC62130 (2R,5S)-Ritlecitinib

    (2R,5S)-PF-06651600

    (2R,5S)-Ritlecitinib (2R,5S)-PF-06651600) 是一种有效的选择性的 JAK3 抑制剂 (IC50=144.8 nM)。详细信息请参考专利US20150158864A1,example 68。
  13. GC62112 Zotiraciclib Zotiraciclib (SB1317; TG02) is a novel small molecule potent CDK/JAK2/FLT3 inhibitor, emerged with potent CDK (IC50 against CDKs 1, 2 and 9 = 9, 5 and 3 nM, respectively), FLT3 (IC50 = 19 nM) and JAK2 (IC50 = 19 nM) potency.
  14. GC19747 CX-6258 HCl

    Pim-Kinase Inhibitor X

    A pan-Pim kinase inhibitor
  15. GC61807 (E/Z)-AG490

    酪氨酸磷酸化抑制剂AG490,(E/Z)-Tyrphostin AG490; (E/Z)-Tyrphostin B42

    (E/Z)-AG490((E/Z)-TyrphostinAG490)是(E)-AG490和(Z)-AG490的消旋体。(E)-AG490是一种酪氨酸激酶抑制剂,可抑制EGFR,Stat-3和JAK2/3。

  16. GC61780 SU5204 SU5204 is a tyrosine kinase inhibitor with IC50 of 4 μM and 51.5 μM for FLK-1 (VEGFR-2) and HER2, respectively.
  17. GC61627 Ochromycinone

    抑胃酶氨酰-21,(Rac)-STA-21

    Ochromycinone((Rac)-STA-21)是一种天然抗生素,也是一种STAT3抑制剂。Ochromycinone可抑制STAT3DNA结合活性,STAT3二聚化。Ochromycinone具有抗癌和抗菌活性。
  18. GC61574 AS1810722 AS1810722是口服有效的STAT6抑制剂,IC50为1.9nM。AS1810722显示出良好的CYP3A4抑制作用。AS1810722是一种稠合双环嘧啶衍生物,具有用于过敏性疾病,例如哮喘和特应性疾病研究的潜力。
  19. GC61524 SC-43 An SHP-1 activator
  20. GC61490 Trastuzumab emtansine

    曲妥珠单抗-美坦新偶联物; Ado-Trastuzumab emtansine; PRO132365; T-DM 1

    Trastuzumab Emtansine(T-DM1,Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that incorporates the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of the microtubule-inhibitory agent DM1.Trastuzumab emtansine has a molecular weight of 145kDa.
  21. GC61473 Trastuzumab deruxtecan

    DS-8201 (solution); DS-8201a (solution)

    Trastuzumab deruxtecan(曲妥珠单抗)是一种人表皮生长因子受体2(HER2)靶向抗体-药物偶联物(ADC),由人源化抗人HER2(抗hHER2)抗体、酶促裂解肽接头和拓扑异构酶I抑制剂(DX-8951衍生物)组成。
  22. GC48839 Nifuroxazide-d4

    硝呋齐特 d4

    An internal standard for the quantification of nifuroxazide
  23. GC50706 JBJ-03-142-02 Highly potent epidermal growth factor receptor (EGFR) and ErbB2 (human epidermal growth factor receptor; HER2) inhibitor
  24. GC47303 Erlotinib-d6 (hydrochloride)

    埃罗替尼-D6盐酸盐,CP-358774-d6 hydrochloride; NSC 718781-d6 hydrochloride; OSI-774-d6 hydrochloride

    An internal standard for the quantification of erlotinib
  25. GC47061 CAY10763 A dual inhibitor of IDO1 and STAT3 activation
  26. GC46503 2-(1,8-Naphthyridin-2-yl)phenol

    3-氨基-2-氯-6-三氟甲基吡啶

    An enhancer of STAT1 activity
  27. GC61161 Osimertinib D6

    AZD-9291-d6; Mereletinib-d6

    OsimertinibD6(AZD-9291D6)是Osimertinib的一种氘代化合物。Osimertinib是一种不可逆和突变的选择性的EGFR抑制剂,抑制EGFRL858R和EGFRL858R/T790M的IC50分别为12和1nM。
  28. GC60868 Gefitinib D8

    吉非替尼杂质-D8,ZD1839-d8

    GefitinibD8(ZD1839D8)是Gefitinib的氘代物。Gefitinib是一种有效的(EGFR)抑制剂,在NR6wtEGFR细胞中IC50值为2-37nM。
  29. GC60805 EMI48 EMI48是EMI1的衍生物,EMI48比EMI1对突变型EGFR具有更大的效力。EMI48抑制EGFR三重突变体。
  30. GC60586 Angoline hydrochloride Angolinehydrochloride是一种有效的选择性的IL6/STAT3信号通路抑制剂,IC50为11.56μM。Angolinehydrochloride抑制STAT3磷酸化及其靶基因表达,并抑制癌细胞增殖。
  31. GC60585 Angoline

    6-甲氧基二氢白屈菜红碱

    Angoline是一种有效的选择性的IL6/STAT3信号通路抑制剂,IC50为11.56μM。Angoline抑制STAT3磷酸化及其靶基因表达,并抑制癌细胞增殖。
  32. GC60567 Afatinib impurity 11 Afatinib impurity 11 is an impurity of afatinib, an EGFR family inhibitor.
  33. GC60154 Erlotinib D6

    CP-358774-d6; NSC 718781-d6; OSI-774-d6

    An internal standard for the quantification of erlotinib
  34. GC39485 CK2/ERK8-IN-1 A dual inhibitor of CK2 and ERK8
  35. GC50480 PF 06651600 malonate Potent and selective JAK3 inhibitor
  36. GC50343 HJC 0416 hydrochloride HJC 0416 hydrochloride 是一种有效的口服活性 STAT3 抑制剂,具有比 Stattic 更强的抗癌特性。 HJC 0416 hydrochloride 是一种用于乳腺癌研究的有前途的抗癌剂。
  37. GC50083 PKI 166 hydrochloride An inhibitor of EGFR
  38. GC50066 Atiprimod dihydrochloride JAK2 inhibitor
  39. GC50026 BIBX 1382 dihydrochloride An EGFR inhibitor
  40. GC50013 AG 1478 hydrochloride

    N-(3-氯苯基)-6,7-二甲氧基-4-喹唑啉胺盐酸盐,Tyrphostin AG-1478 hydrochloride; NSC 693255 hydrochloride

    An inhibitor of EGF receptor kinase
  41. GC39081 Reticuline

    番荔枝碱

    Reticuline 分离自 Litsea cubeba,通过 JAK2/STAT3 和 NF-κB 信号通路显示抗炎作用。Reticuline 还可抑制 TNF-α 和 IL-6 的 mRNA 表达,并降低 JAK2 和 STAT3 的磷酸化水平。
  42. GC39022 Tetramethylcurcumin

    四甲基姜黄素; FLLL31

    Tetramethylcurcumin (FLLL31), a small-molecule signal transducer and activator of transcription 3 (STAT3) inhibitor derived from curcumin, binds selectively to Janus kinase 2 and the STAT3 Src homology-2 domain, which serve crucial roles in STAT3 dimerization and signal transduction.
  43. GC38737 AS2863619 free base A dual inhibitor of Cdk8 and Cdk19
  44. GC38736 AS2863619 A dual inhibitor of Cdk8 and Cdk19
  45. GC45756 Pimozide-d4

    R6238-d4

    An internal standard for the quantification of pimozide
  46. GC38402 BI-4020 BI-4020 is an orally active, non-covalent EGFR inhibitor with IC50 of 0.6 nM and 0.2 nM for EGFRdel19 T790M C797S as biomarker potency and anti-proliferation potency in BaF3 cells, respectively.
  47. GC38386 Golotimod hydrochloride

    SCV 07 hydrochloride; Gamma-D-glutamyl-L-tryptophan hydrochloride

    Golotimod hydrochloride (SCV 07 hydrochloride) 一种具有抗菌活性的免疫调节肽,可显着提高抗结核治疗的功效,刺激胸腺和脾细胞增殖,并改善巨噬细胞功能。Golotimod hydrochloride (SCV 07 hydrochloride) 抑制 STAT3 信号传导并调节接受放疗或放疗与顺铂联合用药的动物模型中口腔粘膜炎的持续时间和严重程度。Golotimod hydrochloride (SCV 07 hydrochloride) 是复发性生殖器单纯疱疹病毒 2 型 (HSV-2) 的潜在治疗药物。
  48. GC38350 Epertinib hydrochloride

    S-22611 hydrochloride

    Epertinib hydrochloride (S-222611 hydrochloride) is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4 with IC50 of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib hydrochloride (S-222611 hydrochloride) exhibits antitumor activity.
  49. GC38180 Cyasterone

    杯苋甾酮

    Cyasterone,一种天然的 EGFR 抑制剂,主要分离自 Ajuga decumbens Thunb (Labiatae)。Cyasterone 通过诱导细胞凋亡 (apoptosis) 和细胞周期阻滞表现出抗增殖作用。 Cyasterone 可作为抗人类肿瘤的临床治疗性药物。
  50. GC38125 Tyrphostin AG30

    酪氨酸磷酸化抑制剂AG30,AG30

    Tyrphostin AG30 (AG30), a potent and selective EGFR tyrosine kinase inhibitor, selectively inhibits self renewal induction by c-ErbB, and is able to inhibit activation of STAT5 by c-ErbB in primary erythroblasts.
  51. GC38081 Theliatinib

    西利替尼; Xiliertinib; HMPL-309

    Theliatinib (HMPL-309) is a highly potent EGFR inhibitor with Ki value of 0.05 nM against the wild type EGFR and IC50 values of 3 nM and 22 nM against EGFR and EGFR T790M/L858R mutant. It demonstrats 50 fold greater selectivity for EGFR compared to 72 other kinases.

Items 201 to 250 of 546 total

per page
  1. 3
  2. 4
  3. 5
  4. 6
  5. 7

Set Descending Direction